List of Tables
Table 1. Global Rare NGR1 Fusion Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiation Therapy
Table 5. Global Rare NGR1 Fusion Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Rare NGR1 Fusion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Rare NGR1 Fusion Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Rare NGR1 Fusion Market Share by Region (2020-2025)
Table 9. Global Rare NGR1 Fusion Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Rare NGR1 Fusion Market Share by Region (2026-2031)
Table 11. Rare NGR1 Fusion Market Trends
Table 12. Rare NGR1 Fusion Market Drivers
Table 13. Rare NGR1 Fusion Market Challenges
Table 14. Rare NGR1 Fusion Market Restraints
Table 15. Global Rare NGR1 Fusion Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Rare NGR1 Fusion Market Share by Players (2020-2025)
Table 17. Global Top Rare NGR1 Fusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare NGR1 Fusion as of 2024)
Table 18. Ranking of Global Top Rare NGR1 Fusion Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Rare NGR1 Fusion Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Rare NGR1 Fusion, Headquarters and Area Served
Table 21. Global Key Players of Rare NGR1 Fusion, Product and Application
Table 22. Global Key Players of Rare NGR1 Fusion, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rare NGR1 Fusion Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Rare NGR1 Fusion Revenue Market Share by Type (2020-2025)
Table 26. Global Rare NGR1 Fusion Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Rare NGR1 Fusion Revenue Market Share by Type (2026-2031)
Table 28. Global Rare NGR1 Fusion Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Rare NGR1 Fusion Revenue Market Share by Application (2020-2025)
Table 30. Global Rare NGR1 Fusion Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Rare NGR1 Fusion Revenue Market Share by Application (2026-2031)
Table 32. North America Rare NGR1 Fusion Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Rare NGR1 Fusion Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Rare NGR1 Fusion Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Rare NGR1 Fusion Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Rare NGR1 Fusion Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Rare NGR1 Fusion Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Rare NGR1 Fusion Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Rare NGR1 Fusion Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Rare NGR1 Fusion Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Rare NGR1 Fusion Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Rare NGR1 Fusion Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Rare NGR1 Fusion Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Rare NGR1 Fusion Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Rare NGR1 Fusion Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Rare NGR1 Fusion Market Size by Country (2026-2031) & (US$ Million)
Table 47. Elevation Oncology Company Details
Table 48. Elevation Oncology Business Overview
Table 49. Elevation Oncology Rare NGR1 Fusion Product
Table 50. Elevation Oncology Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 51. Elevation Oncology Recent Development
Table 52. Merus Company Details
Table 53. Merus Business Overview
Table 54. Merus Rare NGR1 Fusion Product
Table 55. Merus Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 56. Merus Recent Development
Table 57. Hummingbird Bioscience Company Details
Table 58. Hummingbird Bioscience Business Overview
Table 59. Hummingbird Bioscience Rare NGR1 Fusion Product
Table 60. Hummingbird Bioscience Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 61. Hummingbird Bioscience Recent Development
Table 62. Boehringer Ingelheim Company Details
Table 63. Boehringer Ingelheim Business Overview
Table 64. Boehringer Ingelheim Rare NGR1 Fusion Product
Table 65. Boehringer Ingelheim Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 66. Boehringer Ingelheim Recent Development
Table 67. CANbridge Pharmaceuticals Company Details
Table 68. CANbridge Pharmaceuticals Business Overview
Table 69. CANbridge Pharmaceuticals Rare NGR1 Fusion Product
Table 70. CANbridge Pharmaceuticals Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 71. CANbridge Pharmaceuticals Recent Development
Table 72. Salubris Biotherapeutics Company Details
Table 73. Salubris Biotherapeutics Business Overview
Table 74. Salubris Biotherapeutics Rare NGR1 Fusion Product
Table 75. Salubris Biotherapeutics Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 76. Salubris Biotherapeutics Recent Development
Table 77. AVEO Oncology Company Details
Table 78. AVEO Oncology Business Overview
Table 79. AVEO Oncology Rare NGR1 Fusion Product
Table 80. AVEO Oncology Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 81. AVEO Oncology Recent Development
Table 82. Rain Therapeutics Company Details
Table 83. Rain Therapeutics Business Overview
Table 84. Rain Therapeutics Rare NGR1 Fusion Product
Table 85. Rain Therapeutics Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 86. Rain Therapeutics Recent Development
Table 87. Eli Lilly and Company Company Details
Table 88. Eli Lilly and Company Business Overview
Table 89. Eli Lilly and Company Rare NGR1 Fusion Product
Table 90. Eli Lilly and Company Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 91. Eli Lilly and Company Recent Development
Table 92. Jiangsu Hengrui Medicine Company Details
Table 93. Jiangsu Hengrui Medicine Business Overview
Table 94. Jiangsu Hengrui Medicine Rare NGR1 Fusion Product
Table 95. Jiangsu Hengrui Medicine Revenue in Rare NGR1 Fusion Business (2020-2025) & (US$ Million)
Table 96. Jiangsu Hengrui Medicine Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Rare NGR1 Fusion Picture
Figure 2. Global Rare NGR1 Fusion Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rare NGR1 Fusion Market Share by Type: 2024 VS 2031
Figure 4. Immunotherapy Features
Figure 5. Chemotherapy Features
Figure 6. Radiation Therapy Features
Figure 7. Global Rare NGR1 Fusion Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Rare NGR1 Fusion Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Rare NGR1 Fusion Report Years Considered
Figure 13. Global Rare NGR1 Fusion Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Rare NGR1 Fusion Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Rare NGR1 Fusion Market Share by Region: 2024 VS 2031
Figure 16. Global Rare NGR1 Fusion Market Share by Players in 2024
Figure 17. Global Top Rare NGR1 Fusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare NGR1 Fusion as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Rare NGR1 Fusion Revenue in 2024
Figure 19. North America Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Rare NGR1 Fusion Market Share by Country (2020-2031)
Figure 21. United States Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Rare NGR1 Fusion Market Share by Country (2020-2031)
Figure 25. Germany Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Rare NGR1 Fusion Market Share by Region (2020-2031)
Figure 33. China Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Rare NGR1 Fusion Market Share by Country (2020-2031)
Figure 41. Mexico Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Rare NGR1 Fusion Market Share by Country (2020-2031)
Figure 45. Turkey Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Rare NGR1 Fusion Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Elevation Oncology Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 49. Merus Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 50. Hummingbird Bioscience Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 52. CANbridge Pharmaceuticals Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 53. Salubris Biotherapeutics Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 54. AVEO Oncology Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 55. Rain Therapeutics Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 56. Eli Lilly and Company Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 57. Jiangsu Hengrui Medicine Revenue Growth Rate in Rare NGR1 Fusion Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
